Log In
Print this Print this

Vaxfectin-formulated tetravalent dengue DNA vaccine

  Manage Alerts
Collapse Summary General Information
Company Vical Inc.
DescriptionVaccine containing genes encoding pre-membrane and envelope proteins for 4 dengue virus serotypes formulated with the Vaxfectin adjuvant
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationDengue fever
Indication DetailsVaccinate against dengue virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today